pioneer semaglutide Efficacy, safety and cardiovascular outcomes of once‐daily oral in patients with type 2 diabetes: The programme - Thethi - 2020 - Diabetes, Obesity and Metabolism Efficacy and safety of once-daily

Click here to listen to this article Share via If youre on a GLP-1 medication like Ozempic, Wegovy, Mounjaro, semaglutide, or tirzepatide, your scale is likely moving, but are you really tracking what matters

The SURMOUNT program also generated important data on metabolic health improvements beyond weight loss

The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities

Patients whose first overdose involved alcohol had a 40% lower risk during active GLP-1 use, and patients whose first overdose did not involve alcohol had a 37% lower risk

So, let's walk through this process together, the way our own lab technicians would